38903602|t|The role of statins in amyotrophic lateral sclerosis: protective or not?
38903602|a|Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of motor neurons characterized by muscle weakness, muscle twitching, and muscle wasting. ALS is regarded as the third-most frequent neurodegenerative disease, subsequent to Alzheimer's disease (AD) and Parkinson's disease (PD). The World Health Organization (WHO) in 2007 declared that prolonged use of statins may induce development of ALS-like syndrome and may increase ALS risk. Subsequently, different studies have implicated statins in the pathogenesis of ALS. In contrast, results from preclinical and clinical studies highlighted the protective role of statins against ALS neuropathology. Recently, meta-analyses and systematic reviews illustrated no association between long-term use of statins and ALS risk. These findings highlighted controversial points regarding the effects of statins on ALS pathogenesis and risk. The neuroprotective effects of statins against the development and progression of ALS may be mediated by regulating dyslipidemia and inflammatory changes. However, the mechanism for induction of ALS neuropathology by statins may be related to the dysregulation of liver X receptor signaling (LXR) signaling in the motor neurons and reduction of cholesterol, which has a neuroprotective effect against ALS neuropathology. Nevertheless, the exact role of statins on the pathogenesis of ALS was not fully elucidated. Therefore, this narrative review aims to discuss the role of statins in ALS neuropathology.
38903602	23	52	amyotrophic lateral sclerosis	Disease	MESH:D000690
38903602	73	102	Amyotrophic lateral sclerosis	Disease	MESH:D000690
38903602	104	107	ALS	Disease	MESH:D000690
38903602	126	151	neurodegenerative disease	Disease	MESH:D019636
38903602	186	201	muscle weakness	Disease	MESH:D018908
38903602	203	219	muscle twitching	Disease	MESH:D019042
38903602	225	239	muscle wasting	Disease	MESH:D009133
38903602	241	244	ALS	Disease	MESH:D000690
38903602	284	309	neurodegenerative disease	Disease	MESH:D019636
38903602	325	344	Alzheimer's disease	Disease	MESH:D000544
38903602	346	348	AD	Disease	MESH:D000544
38903602	354	373	Parkinson's disease	Disease	MESH:D010300
38903602	375	377	PD	Disease	MESH:D010300
38903602	489	506	ALS-like syndrome	Disease	MESH:D000690
38903602	524	527	ALS	Disease	MESH:D000690
38903602	613	616	ALS	Disease	MESH:D000690
38903602	728	731	ALS	Disease	MESH:D000690
38903602	859	862	ALS	Disease	MESH:D000690
38903602	953	956	ALS	Disease	MESH:D000690
38903602	1062	1065	ALS	Disease	MESH:D000690
38903602	1096	1108	dyslipidemia	Disease	MESH:D050171
38903602	1113	1125	inflammatory	Disease	MESH:D007249
38903602	1175	1178	ALS	Disease	MESH:D000690
38903602	1325	1336	cholesterol	Chemical	MESH:D002784
38903602	1381	1384	ALS	Disease	MESH:D000690
38903602	1464	1467	ALS	Disease	MESH:D000690
38903602	1566	1569	ALS	Disease	MESH:D000690
38903602	Negative_Correlation	MESH:D002784	MESH:D000690

